Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone versus ondansetron for prevention of post-dural puncture headache after cesarean spinal anesthesia
IRCT20260907070952N1Phase 2Recruiting
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in post-dural puncture headache (PDPH) comparing Dexamethasone, Ondansetron and Placebo (3 arms). Primary endpoints: Incidence of post-dural puncture headache at 72 hours, Severity of post-dural puncture headache at 72 hours and 1 more. Started Sep 2026; status: recruiting.
02
Drugs
dexamethasoneondansetron
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20260907070952N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260907070952N1.